Stratify patient disease activity and assess treatment response by measuring damaged collagen

Metabolic dysfunction-associated steatohepatitis (MASH), historically known as non-alcoholic steatohepatitis (NASH), is a dynamic disease marked by periods of fibrotic activity that result in damage to collagen. Quantifying damaged or remodeling collagen in liver samples could allow for population stratification by disease activity levels or monitor response to treatment

Collagen Hybridizing Peptides (CHPs) are the ONLY method for selectively binding damaged collagen, enabling:

  • Detection of fibrosis disease progression up to two times sooner than traditional staining methods
  • Potential stratification for clinical trials based on disease activity rather than stage
  • Determination of treatability: non-active fibrosis may not respond to treatment, which allows for shorter, more cost-effective clinical trials
  • Possibility to reduce clinical trial length by acting as a secondary endpoint for disease activity

CHPs empower collagen targeting for diagnosis and treatment

Our case study shows how CHPs enable:

  • Enhanced clinical trial design with stratification
  • Accurate monitoring of MASH disease activity level in response to treatment
  • Unparalleled clarity with high-contrast staining
See the Data

CHPs: A versatile and sensitive solution for fibrosis characterization

CHPs enable the precise measurement of inflammation and tissue damage in a number of conditions.

Intensity of BCHP staining correlates with disease activity in MASH mouse model

At 3Helix, our CHP products provide:

  • Compatibility with most dyes, imaging probes, and automated staining platforms
  • Utility in histology, in vivo studies, and 3D cell cultures
  • Flexibility for use across any animal model and in human studies
  • The only product on the market to stain damaged collagen with applications available in total collagen staining

Our CHP products are conjugated with a variety of detection motifs for brightfield and fluorescence detection, and they can be customized to meet your unique needs. Visit our products page to learn more.

Explore our Products

Want to learn how CHPs can accelerate your MASH research or clinical trial?

Our experts are here to help.

Contact Us